Malignin, derived from brain tumor cells, complexes and polypeptides thereof

Claim 2

A product, Malignin, derived from brain tumor cells, which forms a single line precipitate with its specific antibody in quantitative precipitin tests and in Ouchterlony gel diffusion tests, is soluble in water and aqueous solutions having an acid or neutral pH, and insoluble at an alkaline pH, and has a spectrophotometric absorption peak wave length of 280 mμ, a molecular weight of about 10,000 and an amino acid composition approximately as follows: ______________________________________ Approx. No. of Residues ______________________________________ Aspartic Acid 9 Threonine 5 Serine 5 Glutamic Acid 13 Proline 4 Glycine 6 Alanine 7 Valine 6 1/2 Cystine 1 Methionine 2 Isoleucine 4 Leucine 8 Tyrosine 3 Phenylalanine 3 Lysine 6 Histidine 2 Arginine 5 Approximate Total 89 ______________________________________ the amino acids cysteic, hydroxyproline, norleucine, ammonia, isodesmosine, hydroxylysine, lysinonorleucine and gamma-aminobutyric acid being absent in detectable amounts.

Claim 3

The antibody, Anti-Malignin, prepared in a mammal in response to the product, Malignin, of claim 1.

Claim 4

The product of claim 1 complexed with an inert carrier.

Claim 5

The product of claim 3 wherein the inert carrier is bromoacetylcellulose.

Claim 6

The product of claim 3 further complexed with the antibody to said Malignin.

Claim 7

The product of claim 4 further complexed with the antibody to said Malignin.

Claim 8

Polypeptides having the physicochemical specificities of the product of claim 1 and derived therefrom by sequential cleavage of units of approximately a molecular weight of 200 down to a molecular weight of approximately 5000.

Claim 9

Polypeptides having the physicochemical specificities of the product of claim 1, and derived therefrom, having a molecular weight approximately defined by the formula 5000+200X=Y; wherein Y is the molecular weight of the polypeptides; and X is an integer from 0-19.

Claim 10

A process for producing a product, Malignin, which comprises extracting artificial brain tumor cells grown in culture with a neutral buffer by repeated disruption of the tissue to solubilize protein fractions, separating from the resulting extract the fraction having a pK range of about 1 to 4, and isolating the product having a molecular weight of about 10,000, said product, Malignin, derived from brain tumor cells, which forms a single line precipitate with its specific antibody in quantitative precipitin tests and Ouchterlony gel diffusion tests, is soluble in water and aqueous solutions having an acid of neutral pH, and insoluble at an alkaline pH, and has a spectrophotometric absorption peak wave length of 280 mμ, a molecular weight of about 10,000 and an amino acid composition approximately as follows: ______________________________________ Approx. No. of Residues ______________________________________ Aspartic Acid 9 Threonine 5 Serine 5 Glutamic Acid 13 Proline 4 Glycine 6 Alanine 7 Valine 6 1/2 Cystine 1 Methionine 2 Isoleucine 4 Leucine 8 Tryosine 3 Phenylalanine 3 Lysine 6 Histidine 2 Arginine 5 Approximate Total 89 ______________________________________ the amino acids cysteic, hydroxyproline, norleucine, ammonia, isodesmosine, hydroxylysine, lysinonorleucine and gammaaminobutyric acid being absent in detectable amounts.

Claim 11

A process for producing a product, Malignin, which comprises extracting artificial brain tumor cells grown in culture with a neutral buffer by repeated disruption of the tissue to solubilize protein fractions, separating from the resulting extract the fraction having a pK range of about 1 to 4, and isolating the product having a molecular weight of about 10,000, said product, Malignin, derived from brain tumor cells, which forms a single line precipitate with its specific antibody in quantitative precipitin tests and Ouchterlony gel diffusion tests, is soluble in water and aqueous solutions having an acid of neutral pH, and insoluble at an alkaline pH, and has a spectrophotometric absorption peak wave length of 280 mμ, a molecular weight of about 10,000 and an amino acid composition approximately as follows: ______________________________________ Approx. No. of Residues ______________________________________ Aspartic Acid 9 Threonine 5 Serine 5 Glutamic Acid 13 Proline 4 Glycine 6 Alanine 7 Valine 6 1/2 Cystine 1 Methionine 2 Isoleucine 4 Leucine 8 Tryosine 3 Phenylalanine 3 Lysine 6 Histidine 2 Arginine 5 Approximate Total 89 ______________________________________ the amino acids cysteic, hydroxyproline, norleucine, ammonia, isodesmosine, hydroxylysine, lysinonorleucine and gammaaminobutyric acid being absent in detectable amounts.

Claim 12

The process of claim 9 wherein said step of separating the fraction having a pK range of from about 1 to 4 is carried out by adding said extract of solubilized proteins into a chromatographic column and eluting with increasingly acidic solvents.

Claim 13

The process of claim 10 wherein said isolating is carried out by filtering the eluate to obtain a fraction containing Malignin and separating Malignin therefrom by thin layer gel chromatography.